Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children
<p>Abstract</p> <p>Infants and children under five years of age are the most vulnerable to malaria with over 1,700 deaths per day from malaria in this group. However, until recently, there were no WHO-endorsed paediatric anti-malarial formulations available.</p> <p>Artemisinin-based combination ther...
-д хадгалсан:
| Үндсэн зохиолчид: | , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
BMC
2009-10-01
|
| Цуврал: | Malaria Journal |
| Онлайн хандалт: | http://www.biomedcentral.com/content/pdf/1475-2875-8-S1-info.pdf |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|